Table 1.
Criteria used to determine whether models replicated age-related and distributional patterns of infection and antibody seen in cross-sectional and post-treatment field data
Pattern identified in field data | Criterion applied to model output | Source |
Cross-sectional | ||
Prevalence of infection by urine test | Prevalence of egg positives 5–80% for 6–14 year olds and for 15–34 year olds | Refs. 14, 44 |
Peaked age intensity curve | Maximum level of infection occurs between age of 6–23 years old | Refs. 7, 14, 16, 44 |
Reduced infection level in adults | Infection level in 24–34 year old age group < 40% of peak age group | Refs. 7, 14, 16, 44 |
Peak shift | Peak infection intensity is lower and occurs in the same or older age group when infection rate is halved | Ref. 12 |
Aggregated egg output | Standardized variance (SV) of mean egg output 2–60 for whole population, for 6–14 year olds and for 15–34 year olds | Refs. 14, 44 |
Antibody switch | Spearman’s ρ for association between two antibody responses < -0.2 | Refs. 13, 14, 20 |
Antibody switch after age of infection peak | Initial (nonprotective) antibody response first falls below its midpoint value in the same or a later age group than peak infection | Refs. 13, 14 |
Post-treatment | ||
Antibody switch after treatment | A2 is ≥200% and A1 is ≤ 50% of respective pre-treatment levels at both 18 and 36 wk post-treatment | Ref. 20 |